This course will be delivered by the trainers virtually as two 3-hour sessions which will take place on Tuesday 16 February 2021 (9:30am – 12:30pm) and Tuesday 23 February 2021 (9:30am – 12:30pm). Click the link below to register your place for the course.
This course, delivered as two 3-hour sessions across two separate days, will provide you with the insights and tools required to communicate a compelling commercial opportunity in a business plan and pitch that a team can unite behind and that prospective investors can support.
You are encouraged to bring a technology opportunity that you are working on (and may commercialise now or in the future) and to work on this throughout the day.
Open to academics, researchers, clinicians and industry representatives, by attending the course you will:
- Understand how to diagnose a technology opportunity in detail including looking at unmet needs, barriers and solutions
- Be able to understand and identify key value milestones along the commercialisation roadmap
- Understand how to manage and mitigate risk
- Use your own technology opportunity to create a business plan
- Understand how to formulate a compelling pitch to investors.
Day 1: 16 February 2021, 9:30am – 12:30pm
- Diagnosing your technology opportunity
- Identifying gaps in your opportunity and how to address potential issues
- What is a value milestone?
Day 2: 23 February 2021, 9:30am – 12:30pm
- An overview of the business planning process
- Pitching your idea to investors
- Examining a successful MedTech start-up case study – from technology to first revenue.
The training course will be run by Nicholas Duggan, Viadynamics
Spaces are limited and registration is essential. Please note in order to ensure all participants get the maximum out of the course by registering you are committing to attending the full duration of the course over both days.
This course will be delivered by the trainer remotely via video conferencing software. Information about how to join the conferencing call will be emailed to everyone that has registered.
Free to staff and postgraduate research students at Translate partner universities (Bradford, Huddersfield, Leeds, Leeds Beckett, Sheffield Hallam and York).
Places for industry and clinical representatives are available at a cost of £45, please email Mohua Siddique (M.Siddique@leeds.ac.uk) to secure your ticket.
Nicholas is an innovation and marketing professional with extensive experience across the medical technology, consumer products, financial services, and ICT sectors. He is a Partner at Viadynamics, a leading innovation and venturing agency.
Nicholas is also a founder and former CEO of Cellesce, a start-up company that aims to transform drug discovery and personalised medicine in the fight against cancer. As CEO, he led the company through successful technology development, IP protection, building out the team, raising seed funding and two subsequent equity raising rounds, to the winning of first customers.